Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N8CI
|
|||
| Drug Name |
PMID25522065-Compound-15
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C23H21ClN2O4S
|
|||
| Canonical SMILES |
CC(C)(COC1=C(C=C(C=C1)N2C(=O)C3=C(C=C(S3)C4=CC=C(C=C4)Cl)C=N2)OC)O
|
|||
| InChI |
1S/C23H21ClN2O4S/c1-23(2,28)13-30-18-9-8-17(11-19(18)29-3)26-22(27)21-15(12-25-26)10-20(31-21)14-4-6-16(24)7-5-14/h4-12,28H,13H2,1-3H3
|
|||
| InChIKey |
QOXWOBOEWLTLQE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
| Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Peptide ligand-binding receptors | |||
| G alpha (q) signalling events | ||||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.